Home » IMMUSOL, INC. ANNOUNCES COLLABORATION
IMMUSOL, INC. ANNOUNCES COLLABORATION
Immusol today announced a three-year discovery, development and commercialization collaboration with Novartis. The agreement has the potential to exceed $78 million in payments to Immusol contingent upon the delivery of targets and compounds and upon the successful development of these compounds by Novartis. Under the terms of the collaboration agreement, Immusol will leverage its proprietary gene inactivation technology to discover biologically validated drug targets for Novartis.
ArriveNet (http://press.arrivenet.com/hea/article.php/682330.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May